{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:52:09Z","timestamp":1794491529807,"version":"4.9.1"},"reference-count":117,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.1080\/17512433.2025.2550727","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T06:58:21Z","timestamp":1755759501000},"page":"589-605","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Treatment management for rosacea: current pharmacological and non-pharmacological options"],"prefix":"10.1080","volume":"18","author":[{"given":"Kyle","family":"Volk","sequence":"first","affiliation":[{"name":"University of South Carolina School of Medicine","place":["Columbia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Ulfers","sequence":"additional","affiliation":[{"name":"Louisiana State University School of Medicine","place":["New Orleans, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin C.","family":"Yi","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Feldman","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, USA"]},{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, USA"]},{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine","place":["Winston-Salem, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00461-0"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0526"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2025.2463093"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1506630"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.077"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14437"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0176-3"},{"issue":"9","key":"e_1_3_6_10_1","first-page":"39","article-title":"Topical ivermectin: data supporting dual modes of action in rosacea","volume":"10","author":"Del Rosso JQ.","year":"2017","unstructured":"Del Rosso JQ. Topical ivermectin: data supporting dual modes of action in rosacea. J Clin Aesthet Dermatol. 2017;10(9):39\u201342.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2019.01.001"},{"key":"e_1_3_6_12_1","first-page":"122","article-title":"Soolantra (ivermectin) 1% cream: a novel, antibiotic-free agent approved for the treatment of patients with rosacea","volume":"8","author":"Raedler LA","year":"2015","unstructured":"Raedler LA. Soolantra (ivermectin) 1% cream: a novel, antibiotic-free agent approved for the treatment of patients with rosacea. Am Health Drug Benefits. 2015;8(Spec Feature):122\u2013125.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001030-00007"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082153"},{"issue":"5","key":"e_1_3_6_15_1","first-page":"495","article-title":"Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics","volume":"6","author":"Conde JF","year":"2007","unstructured":"Conde JF, Yelverton CB, Balkrishnan R, et al. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol. 2007;6(5):495\u2013498.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116219"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.043"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10070757"},{"issue":"3","key":"e_1_3_6_19_1","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore MW","year":"2009","unstructured":"Trumbore MW, Goldstein JA, Gurge RM. Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam. J Drugs Dermatol. 2009;8(3):299\u2013304.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"e_1_3_6_20_1","first-page":"234","article-title":"The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses","volume":"9","author":"Draelos ZD","year":"2010","unstructured":"Draelos ZD. The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses. J Drugs Dermatol. 2010;9(3):234\u2013236.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S115708"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13305"},{"issue":"3","key":"e_1_3_6_23_1","first-page":"32","article-title":"Topical oxymetazoline hydrochloride cream 1% for the treatment of persistent facial erythema of rosacea in adults: a comprehensive review of current evidence","volume":"14","author":"Del Rosso JQ","year":"2021","unstructured":"Del Rosso JQ, Tanghetti E. Topical oxymetazoline hydrochloride cream 1% for the treatment of persistent facial erythema of rosacea in adults: a comprehensive review of current evidence. J Clin Aesthet Dermatol. 2021;14(3):32\u201337.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"e_1_3_6_24_1","first-page":"37","article-title":"Azelaic acid topical formulations: differentiation of 15% gel and 15% foam","volume":"10","author":"Del Rosso JQ","year":"2017","unstructured":"Del Rosso JQ. Azelaic acid topical formulations: differentiation of 15% gel and 15% foam. J Clin Aesthet Dermatol. 2017;10(3):37\u201340.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2023.133955"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15923"},{"issue":"1","key":"e_1_3_6_27_1","first-page":"54","article-title":"A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea","volume":"96","author":"Draelos ZD","year":"2015","unstructured":"Draelos ZD, Elewski BE, Harper JC, et al. A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea. Cutis. 2015;96(1):54\u201361.","journal-title":"Cutis"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/12034754211035091"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02130.x"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02003-w"},{"issue":"8","key":"e_1_3_6_31_1","first-page":"34","article-title":"Efficacy and safety of Microencapsulated benzoyl peroxide cream, 5%, in rosacea: results from two phase III, randomized, vehicle-controlled trials","volume":"16","author":"Bhatia ND","year":"2023","unstructured":"Bhatia ND, Werschler WP, Baldwin H, et al. Efficacy and safety of Microencapsulated benzoyl peroxide cream, 5%, in rosacea: results from two phase III, randomized, vehicle-controlled trials. J Clin Aesthet Dermatol. 2023;16(8):34\u201340.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.s4296"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.11.021"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.6542"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1973.tb03012.x"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530200-000000000-00000"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03445.x"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01769.x"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S427530"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2535"},{"issue":"9","key":"e_1_3_6_41_1","first-page":"54","article-title":"Use of oral isotretinoin in the management of rosacea","volume":"4","author":"Park H","year":"2011","unstructured":"Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol. 2011;4(9):54\u201361.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"e_1_3_6_42_1","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick H","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szab\u00f3 EL, et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges. 2010;8(7):505\u2013515.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"e_1_3_6_43_1","first-page":"45","article-title":"Coprescription of isotretinoin and tetracyclines for acne is rare: an analysis of the National ambulatory medical care survey","volume":"12","author":"Reserva J","year":"2019","unstructured":"Reserva J, Adams W, Perlman D, et al. Coprescription of isotretinoin and tetracyclines for acne is rare: an analysis of the National ambulatory medical care survey. J Clin Aesthet Dermatol. 2019;12(10):45\u201348.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102875"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.06.063"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.06.027"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102783"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-024-04098-9"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03200-1"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14816"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16549"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08702.x"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13144"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-004-0012-x"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09317.x"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2002.00071.x"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16300"},{"issue":"1","key":"e_1_3_6_58_1","first-page":"21","article-title":"Devices and topical agents for rosacea management","volume":"94","author":"Mansouri Y","year":"2014","unstructured":"Mansouri Y, Goldenberg G. Devices and topical agents for rosacea management. Cutis. 2014;94(1):21\u201325.","journal-title":"Cutis"},{"issue":"7","key":"e_1_3_6_59_1","first-page":"30","article-title":"Improving treatment of erythematotelangiectatic rosacea with laser and\/or topical therapy through enhanced discrimination of its clinical features","volume":"9","author":"Micali G","year":"2016","unstructured":"Micali G, Gerber PA, Lacarrubba F, et al. Improving treatment of erythematotelangiectatic rosacea with laser and\/or topical therapy through enhanced discrimination of its clinical features. J Clin Aesthet Dermatol. 2016;9(7):30\u201339.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"e_1_3_6_60_1","first-page":"16","article-title":"Treatment outcomes of Long-Pulsed Nd: YAG laser for two different subtypes of rosacea","volume":"8","author":"Say EM","year":"2015","unstructured":"Say EM, Okan G, G\u00f6kdemir G. Treatment outcomes of Long-Pulsed Nd: YAG laser for two different subtypes of rosacea. J Clin Aesthet Dermatol. 2015;8(9):16\u201320.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1159\/000477353"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15049"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2024.07.004"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0987-7053(96)85003-9"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000277"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2019.82795"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000004057"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203070-00005"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2021.02.004"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111636"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.728360"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114091"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2015.1122810"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113292"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.558741"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4FO03083D"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030411"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ085"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400356"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.059"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1159\/000511984"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019873111"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.5923"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_480_17"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/papr.13165"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.011"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.003"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00189.x"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.01.044"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109366"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.0408"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50970-1"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-00988-8"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.10526"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417748886"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.165"},{"issue":"6","key":"e_1_3_6_97_1","first-page":"42","article-title":"Hydroxocobalamin: an effective treatment for flushing and persistent erythema in rosacea","volume":"15","author":"Huang YW","year":"2022","unstructured":"Huang YW, Huang HP, Hsu CK, et al. Hydroxocobalamin: an effective treatment for flushing and persistent erythema in rosacea. J Clin Aesthet Dermatol. 2022;15(6):42\u201345.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.129"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12687"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.021"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15021"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.098"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16525"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.267"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S392280"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000658"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00892-5"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06415-5"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S473598"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01515.x"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12724"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12439"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14209"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19172"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475419867611"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-015-1850-2"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16354"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2017.1361574"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2025.2550727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:20:57Z","timestamp":1758615657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2025.2550727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,3]]}},"alternative-id":["10.1080\/17512433.2025.2550727"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2025.2550727","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}